Supporting introduction

To ensure the most appropriate medicines are available as quickly as possible for those in need, MMV works closely with its pharma partners and country stakeholders to prepare new products for maximum patient impact after launch.  

This work entails comprehensive pre-launch and launch planning, including clarity of messaging and education about the use of the new products, as well as mobilizing advocates and analyzing forecasts to inform the manufacturing strategy for the product. To drive the acceptance and availability of appropriate malaria medicines in endemic countries, MMV and partners coordinate relevant stakeholders in support of uptake activities.  

MMV is committed to disseminating evidence-based recommendations about the safety and efficacy of medicines for malaria, in line with WHO guidance about the use of these products.